3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
13
Colorectal Neoplasms
6
Neoplasms
4
Thyroid Neoplasms
3
Prostatic Neoplasms
3
Ovarian Neoplasms
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Unmet Fertility Information Needs
1
Thyroid Cancer, Papillary
1
Smoking Cessation
1
Patient Participation
1
Papillary Thyroid Microcarcinoma
1
Neuroma, Acoustic
1
Melanoma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Kidney Neoplasms
1
Healthy Volunteers
1
Depression
1
Dementia
1
Colorectal Cancer Screening
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
COVID-19
1
Breast Carcinoma In Situ
1
Behavior
1
Advanced Cancer
1
Interventions
Paclitaxel
326
Carboplatin
318
Bevacizumab
167
Gemcitabine
106
pembrolizumab
101
liposomal doxorubicin
100
Cyclophosphamide
96
Topotecan
93
Cisplatin
89
olaparib
86
niraparib
60
Docetaxel
56
Taxes
52
Doxorubicin
50
Drug Therapy
42
fludarabine
40
Filgrastim
39
Nivolumab
37
Etoposide
32
Specimen Handling
31
Magnetic Resonance Spectroscopy
29
Immunoglobulin G
27
Disulfides
27
Peripheral Blood Stem Cell Transplantation
26
Albumin-Bound Paclitaxel
25
durvalumab
24
aldesleukin
24
Hyperthermic Intraperitoneal Chemotherapy
24
Oxaliplatin
23
Biopsy
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Ovarian Neoplasms
×
Decision Support Techniques
×
Clear all
NCT05512260
2026-02-11
BESTa
Karolinska Institutet
Phase NA
Withdrawn
NCT02259699
2019-06-10
PCOA
University of California, Irvine
Phase NA
Completed
124 enrolled
11 charts